Erchonia Corporation
The purpose of this clinical study is to determine the effectiveness of the Erchonia® GVS in improving the appearance of skin laxity on the abdominal region.
This clinical study is a prospective open-label design with post-study independent blinded outcome analysis to evaluate the efficacy of the Erchonia® GVS Laser in improving the appearance of skin laxity on the abdominal region. Participants will receive 8 treatments over the course of 4 weeks.
Inclusion Criteria: * Subject has signed a written informed consent form. * Male or female 22 to 70 years of age, inclusive. * Desire to undergo treatment for skin laxity of the abdomen. * Subject's score on the skin laxity scale for skin on the abdomen is 1 (mild) or 2 (moderate). * Subject agrees to maintain his/her weight (i.e., within 5%) by not making any major changes in diet, exercise or medication routine during the course of the study. * Subject agrees to refrain from taking any medication(s) or supplements(s), whether prescription or OTC, or undergo any procedures indicated for weig…
405nm violet and 520nm green laser light therapy.
Arctuva estimate
Verify or correct the compensation shown for this listing.